| Symbol | Company | Weighting |
|---|---|---|
| EYPT | EYEPOINT PHARMACEUTICALS | 2.86% |
| ABVX | ABIVAX SA | 2.80% |
| INSM | INSMED INC | 2.52% |
| AKRO | AKERO THERAPEUTICS INC | 2.22% |
| PSNL | PERSONALIS | 2.18% |
| SPRY | ARS PHARMACEUTICALS | 2.17% |
| IMVT | IMMUNOVANT INC | 2.08% |
| CDXS | CODEXIS INC | 2.08% |
| LENZ | LENZ THERAPEUTICS | 2.06% |
| CYTK | CYTOKINETICS INC | 2.03% |
| ICLR | ICON PLC | 1.99% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | 1.96% |
| PCVX | VAXCYTE INC | 1.87% |
| SMMT | SUMMIT THERAPEUTICS INC. | 1.86% |
| HALO | HALOZYME THERAPEUTICS INC | 1.85% |
| RMD | RESMED INC | 1.79% |
| MDT | MEDTRONIC PLC | 1.78% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.75% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.74% |
| AZN | ASTRAZENECA PLC-ADR | 1.72% |
| SYK | STRYKER CORP | 1.72% |
| GKOS | GLAUKOS CORPORATION | 1.70% |
| BDX | BECTON DICKINSON & CO | 1.69% |
| DNLI | DENALI THERAPEUTICS INC. | 1.68% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.68% |
| ALC | ALCON INC | 1.67% |
| DXCM | DEXCOM INC | 1.66% |
| DHR | DANAHER CORP | 1.66% |
| CRNX | CRINETICS PHARMACEUTICALS INC | 1.64% |
| ABBV | ABBVIE INC | 1.63% |
| TARS | TARSUS PHARMACEUTICALS | 1.62% |
| RVMD | REVOLUTION MEDICINES INC | 1.62% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.61% |
| BSX | BOSTON SCIENTIFIC | 1.61% |
| ARGX | ARGENX SE ADR | 1.60% |
| KRRO | KORRO BIO | 1.57% |
| SNY | SANOFI- AVENTIS- ADR | 1.57% |
| TVTX | TRAVERE THERAPEUTICS INC | 1.56% |
| THC | TENET HEALTHCARE CORP | 1.55% |
| UNH | UNITEDHEALTH GROUP INC | 1.55% |
| HUM | HUMANA INC | 1.55% |
| ABT | ABBOTT LABORATORIES | 1.55% |
| MCK | MCKESSON CORP | 1.55% |
| EWTX | EDGEWISE THERAPEUTICS | 1.53% |
| HCA | HCA HOLDINGS INC | 1.53% |
| RGEN | REPLIGEN CORP | 1.51% |
| ZTS | ZOETIS INC | 1.51% |
| VCEL | VERICEL CORP | 1.48% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.47% |
| ADMA | ADMA BIOLOGICS, INC. | 1.46% |
| GMED | GLOBUS MEDICAL INC CLASS A | 1.44% |
| ISRG | INTUITIVE SURGICAL INC | 1.43% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.37% |
| DYN | DYNE THERAPEUTICS, INC. | 1.31% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.23% |
| ELV | ELEVANCE HEALTH INC | 1.23% |
| REGN | REGENERON PHARMACEUTICALS | 1.22% |
| TNDM | TANDEM DIABETES CARE INC | 1.11% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.63% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.